Income Taxes
9 Months Ended 12 Months Ended
Oct. 31, 2021
Jan. 31, 2021
Income Tax Disclosure [Line Items]    
Income Taxes
8.
Income Taxes
The income tax provision for interim periods is determined using an estimate of the Company’s annual effective tax rate as adjusted for discrete items arising in that quarter. The effective income tax rate was (0.0)% and (0.1)% for the nine months ended October 31, 2021 and 2020, respectively. The effective tax rate differs from the U.S. statutory rate primarily due to the full valuation allowances on the Company’s net domestic deferred tax assets and impact of foreign tax rate differential.
On March 27, 2020, the CARES Act was enacted and signed into U.S. law to provide economic relief to individuals and businesses facing economic hardship as a result of the
COVID-19
pandemic. Changes in tax laws or rates are accounted for in the period of enactment. The income tax provisions of the CARES Act did not have a significant impact on our current taxes, deferred taxes, or uncertain tax positions.
9.
Income Taxes
The provision for income taxes consists of the following for the years ended January 31:
 
    
2021
    
2020
 
Current income taxes
                 
Federal
   $ —        $ —    
State
     8        8  
Foreign
     69        3  
Deferred income taxes
     —          —    
    
 
 
    
 
 
 
Total income tax expense
   $ 77      $ 11  
    
 
 
    
 
 
 
For the years ended January 31, 2021 and 2020, the foreign income (loss) before provision for income tax was $660 and $(1,123), respectively. For the years ended January 31, 2021 and 2020, the domestic loss before provision for income tax was $(55,956) and $(46,735), respectively.
Indefinite reinvestment is determined by management’s judgment about and intentions concerning the future operations of the Company. As part of our business strategies, we have determined that, all earnings from our foreign continuing operations will be deemed indefinitely reinvested outside of the United States. Our plans to indefinitely reinvest certain earnings are supported by projected working capital and long-term capital requirements in each foreign subsidiary location in which the earnings are generated.
 
 
A reconciliation of income tax expense at the U.S. federal statutory income tax rate to annual income tax expense at the Company’s effective tax rate is as follows:
 
    
2021
          
2020
        
Income tax expense computed at U.S. federal statutory income tax rate
   $ (11,628      21.0   $ (10,050      21.0
State income taxes
     (2,257      4.1     (1,951      4.1
Permanent items
     321        -0.6     943        -2.0
Valuation Allowance
     13,632        -24.6     11,617        -24.3
Other
     9        0.0     (548      1.2
    
 
 
    
 
 
   
 
 
    
 
 
 
Income tax expense computed at U.S. federal statutory income tax rate
  
$
77
 
  
 
-0.1
 
$
11
 
  
 
0.0
Deferred income taxes reflect temporary differences in the recognition of revenue and expenses for income tax reporting and financial statement purposes. Significant components of the Company’s deferred tax assets (liabilities) are as follows:
 
    
2021
    
2020
 
Deferred tax assets
                 
Net operating loss carryforward
   $ 38,933      $ 25,296  
Accruals and other
     757        463  
Intangibles
     136        135  
Depreciation and amortization
     70        —    
Deferred Revenue
     2,754        3,094  
    
 
 
    
 
 
 
Gross deferred tax assets
     42,650        28,988  
Valuation allowance
     (41,849      (28,214
    
 
 
    
 
 
 
Net deferred tax asset
     801        774  
Deferred tax liabilities
                 
Depreciation and amortization
     —          (23
Deferred costs
     (801      (751
    
 
 
    
 
 
 
Net deferred tax assets (liabilities)
   $ —        $ —    
    
 
 
    
 
 
 
The table below details the activity of the deferred tax asset valuation allowance:
 
Deferred tax asset valuation allowance
  
Beginning
Balance
    
Charged
to Costs
&
Expenses
    
Deductions
    
Ending
Balance
 
Year Ended
                                   
January 31, 2021
   $ 28,214        13,635        —        $ 41,849  
January 31, 2020
   $ 16,598        11,616        —        $ 28,214  
As of January 31, 2020 and January 31, 2019, the Company had net operating loss carryforwards (NOLs) available to offset federal taxable income of approximately $154,932 and $99,960 respectively. $25,270 of the federal NOLs expire on various dates through 2037 and $129,662 are able to be carried forward indefinitely to offset 80% of future taxable income. The company has tax effected state NOL carryforwards
 
of approximately $6,223 as of January 31, 2021 and $4,051 as of January 31, 2020 that expire on various dates through 2037.
In accordance with IRC Section 382, the extent to which net operating loss carryforwards can be used to offset future taxable income may be limited, depending on the extent of any ownership changes as defined by federal and various state and local jurisdictions. These limitations may result in the expiration of net operating loss carry forwards before utilization.
In assessing the realizability of its net deferred tax assets, management considers whether it is more likely than not that some portion or all of the net deferred tax assets will be recognized. The ultimate realization of the net deferred tax assets is dependent upon the generation of taxable income during the periods in which temporary differences become deductible. Management considers taxes paid, if any, scheduled reversal of deferred tax liabilities, projected future taxable income, and tax planning strategies that can be implemented by the Company in making this assessment. Based upon the level of historical taxable income, scheduled

reversal of deferred tax liabilities, and projections for taxable income over the periods in which the temporary differences become deductible based on available tax planning strategies, management presently believes it is more likely than not that the Company may not realize all of the benefits of these deductible differences and, accordingly, has established a valuation allowance against the net deferred tax assets at January 31, 2021 and 2020.
The Company recognizes a tax position taken or expected to be taken (and any associated interest and penalties) if it is more likely than not that it will be sustained upon examination, including resolution of any related appeals or litigation processes, based on the technical merits of the position. The Company measures the tax position at the largest amount of benefit that is greater than 50% likely of being realized upon ultimate settlement. Management evaluated all income tax positions and determined that there were no uncertain tax positions that required reserves as of January 31, 2021 and 2020. The Company files tax returns in the United States federal jurisdiction and in many state jurisdictions. The tax years 2017 through 2021 remain open to examination by the major taxing jurisdictions to which the company is subject. No examinations are currently open.
On March 27, 2020, the Coronavirus Aid, Relief and Economic Security (CARES) Act was enacted and signed into U.S. law to provide economic relief to individuals and businesses facing economic hardship as a result of the
COVID-19
pandemic. Changes in tax laws or rates are accounted for in the period of enactment. The income tax provisions of the CARES Act do not have a significant impact on our current taxes, deferred taxes, or uncertain tax positions.